MedPath

Ultrasound Elastography in Diagnosing Patients With Kidney or Liver Solid Focal Lesions

Not Applicable
Completed
Conditions
Kidney Tumor
Adult Primary Liver Cancer
Interventions
Procedure: ultrasound elasticity imaging
Registration Number
NCT01908166
Lead Sponsor
Stanford University
Brief Summary

This clinical trial studies ultrasound elastography in diagnosing patients with kidney or liver solid focal lesions. New diagnostic procedures, such as ultrasound elastography, may be a less invasive way to check for kidney or liver solid focal lesions.

Detailed Description

PRIMARY OBJECTIVES:

I. To determine the utility of ultrasound elastography in correlation with kidney or liver biopsy or magnetic resonance imaging (MRI) or computed tomography (CT) results.

OUTLINE:

Patients undergo ultrasound elastography.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
61
Inclusion Criteria
  • There are no restrictions on life expectancy
  • Eastern Cooperative Oncology Group (ECOG) or Karnofsky performance status will not be employed
  • Patients of any ethnic background
  • Ability to understand and the willingness to sign a written informed consent document
Read More
Exclusion Criteria
  • Patients should not be taking other investigational agents
  • No requirements due to co-morbid disease or intercurrent illness, as needed
  • No restrictions on allergic reactions as no imaging agent will be used
  • Concomitant medications for treatment of the target lesion
  • Pregnant or nursing patients will be excluded from the study
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Diagnostic (ultrasound elastography)ultrasound elasticity imagingPatients undergo ultrasound elastography.
Primary Outcome Measures
NameTimeMethod
Strain ratio for all lesions measured by comparing the lesion to the adjacent normal tissueUp to 36 months

Suspicious liver and kidney lesions will be analyzed separately on a per-lesion basis. Within each population, the strain ratio of cases and controls will be compared using the Wilcoxon rank sum test, and the analysis will be illustrated using the non-parametric receiver operating characteristic (ROC).

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Stanford University, School of Medicine

🇺🇸

Stanford, California, United States

© Copyright 2025. All Rights Reserved by MedPath